Get started
Author

M V Chandrakanth

Observed names: Chandrakanth M, Chandrakanth, M V, Chandrakanth, M.V, M. V. Chandrakanth, M.V. Chandrakanth, M.V.K. Chandrakanth, MV Chandrakanth
Institution: Narayana Health
ORCID: 0000-0002-4574-2599
Observed ORCID: 0000-0002-4574-2599
OpenAlex ID: A5111335959
Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen ‘OGS-12’
2017 · Jyoti Bajpai, Arun Chandrasekharan, et al. · European Journal of Cancer · 55
Expectations and preferences for palliative chemotherapy in head and neck cancers patients
2016 · Vijay Patil, Amit Joshi, et al. · Oral Oncology · 26
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients
2018 · Vijay Patil, Amit Joshi, et al. · South Asian Journal of Cancer · 14
PDF
Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy
2018 · Vijay M Patil, Nikhil Pande, et al. · CNS Oncology · 11
PDF
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden
2017 · Amit Joshi, Vijay M. Patil, et al. · South Asian Journal of Cancer · 8
ROS1 rearranged nonsmall cell lung cancer and crizotinib: An Indian experience
2017 · V Noronha, MV Chandrakanth, et al. · Indian Journal of Cancer · 8
Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: A single center experience
2014 · Hasmukh Jain, Manju Sengar, et al. · Hematology/Oncology and Stem Cell Therapy · 8
Evolving Treatment Paradigms in Metastatic Hormone-Sensitive Prostate Cancer: Expert Narrative Review
2025 · Vineet Talwar, Kaushal Kalra, et al. · Current Oncology · 6
PDF
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC
2023 · Vanita Noronha, Nandini S. Menon, et al. · JTO Clinical and Research Reports · 6
PDF
Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status
2017 · MV Chandrakanth, V Noronha, et al. · Indian Journal of Cancer · 6
Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India
2023 · M V Chandrakanth, Vivek Agarwala, et al. · F1000Research · 3
Ceritinib in anaplastic lymphoma kinase-positive nonsmall cell lung cancer among patients who were previously exposed to crizotinib: Experience from the Indian subcontinent
2017 · AP Joshi, MV Chandrakanth, et al. · Indian Journal of Cancer · 3
Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
2025 · MV Chandrakanth, Vivek Agarwala, et al. · Frontiers in Oncology · 2
PDF
TP Ex for analysis- Weekly paclitaxel baseline data- Revised.xlsx
2023 · Agarwala, Vivek, Chandrakanth, M V, et al. · Figshare · 2
Study of markers of atherosclerosis including insulin resistance in patients with chronic renal failure
2012 · M. V. Chandrakanth, Sidhartha Das, et al. · Journal of Diabetes Mellitus · 2
PDF
275P Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: A double institution retrospective analysis from India
2020 · V. Agarwala, M.V. Chandrakanth, et al. · Annals of Oncology · 1
Practice Patterns and Outcomes in Advanced Colorectal Cancers From a Multi-Institutional Analysis: Real-World Evidence From India
2025 · Anant Ramaswamy, Ramjas Prajapati, et al. · JCO Global Oncology
PDF
Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and /or metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India
2025 · M V Chandrakanth, Vivek Agarwala, et al. · F1000Research
TP Ex for analysis- Weekly paclitaxel baseline data- revision 2.xlsx
2023 · Agarwala, Vivek, Chandrakanth, M.V, et al. · Figshare
Outcomes of Treatment of Unresectable Esophageal Carcinoma Treated With Chemoradiotherapy and Oral Metronomic Chemotherapy: an Experience From a Rural Cancer Center
2016 · Joydeep Ghosh, Nandini Sharma, et al. · Eastern Journal of Medical Sciences
PDF
Blastic plasmacytoid dendritic cell neoplasm: A rare subtype of myeloid leukemia
2014 · Hasmukh Jain, Manju Sengar, et al. · Hematology/Oncology and Stem Cell Therapy
PDF
Works count: 21
Citation count: 161
H-index: 7
I10-index: 4
Year
Topic
Type